Manulife (Manufacturers Life Insurance)’s Tourmaline Bio TRML Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,848	Closed	-$280K	–	2953
2025 Q3	$280K	Buy	+5,848	New	+$162K	﹤0.01%	2421
2024 Q4	–	Sell	-8,804	Closed	-$226K	–	3027
2024 Q3	$226K	Buy	+8,804	New	+$147K	﹤0.01%	2611
2022 Q3	–	Sell	-1,012	Closed	-$45.6K	–	2995
2022 Q2	$45.6K	Buy	+1,012	New	+$79.8K	﹤0.01%	2991
2022 Q1	–	Sell	-1,077	Closed	-$165	–	3184
2021 Q4	$165	Buy	+1,077	New	+$159K	﹤0.01%	2964

Manulife (Manufacturers Life Insurance)'s TRML Position: Q4 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 5,848 shares — an estimated $280K sold.

Manulife (Manufacturers Life Insurance) first reported a position in TRML in Q4 2021 and held it in 4 quarters. The position peaked at $280K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Manulife (Manufacturers Life Insurance) reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 5,848 Tourmaline Bio shares in Q4 2025, an estimated $280K.
Manulife (Manufacturers Life Insurance) first reported a position in Tourmaline Bio in Q4 2021 and held it in 4 quarters.
Manulife (Manufacturers Life Insurance)'s Tourmaline Bio position peaked at $280K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2025, filed 13 Feb 2026.